Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Justin C Chia"'
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/348aa0521cc34138ae944b4ac4855921
Publikováno v:
SAGE Open Medical Case Reports, Vol 9 (2021)
Mycobacterium elephantis was first described when isolated from an elephant that succumbed to lung abscess. However, despite this namesake, it is not associated with animals and has been described most often as a probable colonizer rather than pathog
Externí odkaz:
https://doaj.org/article/216217a6648040fd9af10c4c88db906c
Publikováno v:
JAAD Case Reports, Vol 24, Iss , Pp 48-51 (2022)
Externí odkaz:
https://doaj.org/article/297299271baa490084d9679de90c53aa
Publikováno v:
JAAD Case Reports, Vol 27, Iss , Pp 137-139 (2022)
Externí odkaz:
https://doaj.org/article/17952e4be94f4cdebf678f6f3c5705b3
Publikováno v:
Dermatologic Therapy. 2023:1-11
Cutaneous T-cell lymphoma (CTCL) is an uncommon non-Hodgkin lymphoma characterized by skin involvement, with the most recognized subtypes being mycosis fungoides (MF) and Sezary syndrome (SS). Interferon has been an established treatment for MF/SS si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0a573370c4887cd42c28da1444127ab
https://doi.org/10.1155/2023/7171937
https://doi.org/10.1155/2023/7171937
Publikováno v:
Pediatric Dermatology. 39:757-760
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05c359da057a764b4338cc377a7e3236
https://doi.org/10.1111/pde.15058
https://doi.org/10.1111/pde.15058
Autor:
Taylor E. Woo, Justin C. Chia
Publikováno v:
Journal of Cutaneous Medicine and Surgery. 27:184-184
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62ad98b7cb81c653508901945e17b32d
https://doi.org/10.1177/12034754231152216
https://doi.org/10.1177/12034754231152216
Autor:
Justin C, Chia, P Régine, Mydlarski
Publikováno v:
The Journal of dermatological treatment. 28(4)
Omalizumab is a recombinant humanized monoclonal antibody that inhibits the binding of immunoglobulin E (IgE) to the high-affinity IgE receptor (FceRI) on the surface of mast cells and basophils. Omalizumab has been approved for use in asthma, and ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::25646b3f364228ee354cc2a3d8d40275
https://pubmed.ncbi.nlm.nih.gov/27759482
https://pubmed.ncbi.nlm.nih.gov/27759482